Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Victória Laysna Dos Anjos SantosGraduate Program in Health and Biological Sciences, Universidade Federal do Vale do São Francisco, Av. José de Sá Maniçoba s/n, Campus Centro, Petrolina 56304-917, Brazil.
Arlan de Assis GonsalvesGraduate Program in Health and Biological Sciences, Universidade Federal do Vale do São Francisco, Av. José de Sá Maniçoba s/n, Campus Centro, Petrolina 56304-917, Brazil.
Délis Galvão GuimarãesGraduate Program in Biotechnology, Rede Nordeste de Biotecnologia-RENORBIO, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Campus Lagoa Nova, Natal 59078-900, Brazil.
Sidney Silva SimplicioGraduate Program in Health and Biological Sciences, Universidade Federal do Vale do São Francisco, Av. José de Sá Maniçoba s/n, Campus Centro, Petrolina 56304-917, Brazil.ORCID 0000-0002-9061-4035
Helinando Pequeno de OliveiraGraduate Program in Materials Science, Universidade Federal do Vale do São Francisco, Av. Antônio Carlos Magalhães 510, Campus Juazeiro, Juazeiro 48902-300, Brazil.ORCID 0000-0002-7565-5576
Lara Polyana Silva RamosGraduate Program in Pharmaceutical Sciences, Universidade Federal do Piauí, Teresina 64049-550, Brazil.
Marcília Pinheiro da CostaGraduate Program in Pharmaceutical Sciences, Universidade Federal do Piauí, Teresina 64049-550, Brazil.ORCID 0000-0001-6093-6781
Fátima de Cássia Evangelista de OliveiraGraduate Program in Physiology and Pharmacology, Universidade Federal do Ceará, Fortaleza 60430-270, Brazil.ORCID 0000-0002-4737-5008
Claudia PessoaGraduate Program in Physiology and Pharmacology, Universidade Federal do Ceará, Fortaleza 60430-270, Brazil.ORCID 0000-0002-4344-4336
Cleônia Roberta Melo AraújoGraduate Program in Health and Biological Sciences, Universidade Federal do Vale do São Francisco, Av. José de Sá Maniçoba s/n, Campus Centro, Petrolina 56304-917, Brazil.ORCID 0000-0003-0422-5541
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88881.708019/2022-01Fundação de Amparo à Ciência e Tecnologia de Pernambuco IBPG-0457-1.06/20
6 · The paper itself
Abstract
Theranostics combines therapeutic and imaging diagnostic techniques that are extremely dependent on the action of imaging agent, transporter of therapeutic molecules, and specific target ligand, in which fluorescent probes can act as diagnostic agents. In particular, naphthoimidazoles are potential bioactive heterocycle compounds to be used in several biomedical applications. With this aim, a group of seven naphth[1,2-
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.